GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (OTCPK:FAMDF) » Definitions » 3-Year EBITDA Growth Rate

Futura Medical (Futura Medical) 3-Year EBITDA Growth Rate : -24.20% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Futura Medical 3-Year EBITDA Growth Rate?

Futura Medical's EBITDA per Share for the six months ended in Dec. 2023 was $-0.02.

During the past 3 years, the average EBITDA Per Share Growth Rate was -24.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 16.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Futura Medical was 33.10% per year. The lowest was -31.70% per year. And the median was -5.45% per year.


Competitive Comparison of Futura Medical's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Futura Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Futura Medical's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Futura Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Futura Medical's 3-Year EBITDA Growth Rate falls into.



Futura Medical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Futura Medical  (OTCPK:FAMDF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Futura Medical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Futura Medical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Futura Medical (Futura Medical) Business Description

Traded in Other Exchanges
Address
40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG
Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief.